Skip to content
Disclosery

MWG Management Ltd.

Follow

13F filer, CIK 1845151, Washington, DC

MWG Management Ltd. reported $118,877,448 across 3 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-002084

Period
2023-12-31
Reported value
$119M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0000950123-24-002084, largest first. % of portfolio is the value over $118,877,448, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,346,934 shares 2,346,934$63.9M53.74%0Timeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 20,162,332 shares 20,162,332$39.1M32.9%0
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,792,210 shares 1,792,210$15.9M13.36%0Timeline

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-24-002084 base2024-02-14acceptance time not in the bulk data set